Market Value127,752,976
Total Holdings45
File Date2024-01-30
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CABA / Cabaletta Bio, Inc.
RXDX / Prometheus Biosciences Inc
PSTX / Poseida Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
AUPH / Aurinia Pharmaceuticals Inc.
DNLI / Denali Therapeutics Inc.
MASI / Masimo Corporation
/ Ambrx Biopharma Inc
NBIX / Neurocrine Biosciences, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
CAH / Cardinal Health, Inc.
UNH / UnitedHealth Group Incorporated
FOLD / Amicus Therapeutics, Inc.
FUSN / Fusion Pharmaceuticals Inc.
SWAV / Shockwave Medical, Inc.
RPRX / Royalty Pharma plc
DXCM / DexCom, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
ZVRA / Zevra Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
DOCS / Doximity, Inc.
OPCH / Option Care Health, Inc.
INSP / Inspire Medical Systems, Inc.
LLY / Eli Lilly and Company
KRYS / Krystal Biotech, Inc.
SYK / Stryker Corporation
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TMO / Thermo Fisher Scientific Inc.
GILD / Gilead Sciences, Inc.
AKRO / Akero Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
AMGN / Amgen Inc.
CNC / Centene Corporation
IONS / Ionis Pharmaceuticals, Inc.
COR / Cencora, Inc.
MRUS / Merus N.V.
BMY / Bristol-Myers Squibb Company
CVS / CVS Health Corporation
MRNA / Moderna, Inc.
CYTK / Cytokinetics, Incorporated
MORF / Morphic Holding, Inc.
CI / The Cigna Group
VTRS / Viatris Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
MOH / Molina Healthcare, Inc.
OM / Outset Medical, Inc.
UTMD / Utah Medical Products, Inc.
IQV / IQVIA Holdings Inc.
PRTA / Prothena Corporation plc
BMRN / BioMarin Pharmaceutical Inc.
ABBV / AbbVie Inc.
EXAS / Exact Sciences Corporation
PFE / Pfizer Inc.
VRTX / Vertex Pharmaceuticals Incorporated
KRTX / Karuna Therapeutics, Inc.
BLU / Bellus Health Inc
ACLX / Arcellx, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
ITCI / Intra-Cellular Therapies, Inc.
ELV / Elevance Health, Inc.
BBIO / BridgeBio Pharma, Inc.
MRK / Merck & Co., Inc.
HRMY / Harmony Biosciences Holdings, Inc.
BSX / Boston Scientific Corporation